Home/Pipeline/exciplex® device

exciplex® device

Localized Alopecia Areata, Vitiligo, Psoriasis

ApprovedActive

Key Facts

Indication
Localized Alopecia Areata, Vitiligo, Psoriasis
Phase
Approved
Status
Active
Company

About Clarteis

Clarteis is a specialized medical device firm focused on dermatology phototherapy. Its core innovation is the exciplex® device, which it claims is the smallest monochromatic excimer light source for treating localized skin conditions like Vitiligo, Alopecia Areata, and Psoriasis. The company targets a global market of dermatologists and medical device distributors, positioning its product as an office-based, precise treatment alternative to larger, less targeted phototherapy systems. As a private entity, it appears to be in the commercial stage with its first product, though its specific financial and operational scale is not publicly detailed.

View full company profile